DPP Zika IgM System

GUDID 00607158000106

The DPP Zika IgM System is intended for the presumptive qualitative detection of Zika virus IgM antibodies in human serum (plain or separation gel), potassium-EDTA plasma, potassium EDTA venous whole blood, or fingerstick whole blood specimens, collected from individuals meeting the CDC Zika virus clinical criteria (e.g., a history of clinical signs and symptoms associated with Zika virus infection) and/or CDC Zika virus epidemiological criteria (e.g., history of residence in or travel to a geographic region with active Zika transmission at the time of travel, or other epidemiological criteria for which Zika virus testing may be indicated).

Chembio Diagnostic Systems Inc.

Zika virus immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA) Zika virus immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA) Zika virus immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA) Zika virus immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA) Zika virus immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA) Zika virus immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA) Zika virus immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA) Zika virus immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA) Zika virus immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA) Zika virus immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA) Zika virus immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA) Zika virus immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA) Zika virus immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA) Zika virus immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA)

• Primary Device ID: 00607158000106
• NIH Device Record Key: b1324d01-543c-4023-8282-9e1124172e4c
• Commercial Distribution Status: In Commercial Distribution
• Brand Name: DPP Zika IgM System
• Version Model Number: 65-9560-0
• Company DUNS: 160348470
• Company Name: Chembio Diagnostic Systems Inc.
• Device Count: 1
• DM Exempt: false
• Pre-market Exempt: false
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: false
• Device Kit: true
• Device Combination Product: false
• Single Use: true
• Lot Batch: false
• Serial Number: false
• Manufacturing Date: false
• Expiration Date: false
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: false
• RX Perscription: false
• OTC Over-The-Counter: false

Device Identifiers

Device Issuing Agency	Device ID
GS1	00607158000106 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

• Premarket Notification: K200506

FDA Product Code

• QFO: Zika Virus Serological Reagents

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: false

Device Entry Metadata

• Public Version Status: New
• Device Record Status: Published
• Public Version Number: 1
• Public Version Date: 2020-08-14
• Device Publish Date: 2020-08-06

Devices Manufactured by Chembio Diagnostic Systems Inc.

• 00607158000113 - DPP Zika IgM Micro Reader: 2021-10-27 The DPP® Micro Reader for use with the DPP Zika IgM Assay System is a reflectance reader configured to read exclusive results o
• 00607158000083 - DPP HIV-Syphilis: 2021-01-06 The DPP® HIV-Syphilis is a single-use rapid, qualitative, multiplex, immunoassay for the detection of antibodies to Human Immun
• 00607158000106 - DPP Zika IgM System: 2020-08-14The DPP Zika IgM System is intended for the presumptive qualitative detection of Zika virus IgM antibodies in human serum (plain or separation gel), potassium-EDTA plasma, potassium EDTA venous whole blood, or fingerstick whole blood specimens, collected from individuals meeting the CDC Zika virus clinical criteria (e.g., a history of clinical signs and symptoms associated with Zika virus infection) and/or CDC Zika virus epidemiological criteria (e.g., history of residence in or travel to a geographic region with active Zika transmission at the time of travel, or other epidemiological criteria for which Zika virus testing may be indicated).
• 00607158000106 - DPP Zika IgM System: 2020-08-14 The DPP Zika IgM System is intended for the presumptive qualitative detection of Zika virus IgM antibodies in human serum (plain
• 00607158000007 - Chembio DPP HIV 1/2 Assay: 2018-07-06 The Chembio DPP® HIV 1/2 Assay is a single-use immunochromatographic test for the detection of antibodies to Human Immunodefici
• 00607158000021 - Clearview Complete HIV 1/2: 2018-07-06 The Clearview® COMPLETE HIV 1/2 assay is a single-use immunochromatographic test for the detection of antibodies to Human Immun
• 00607158000038 - Clearview HIV Reactive/Nonreactive Controls: 2018-07-06 The Clearview® HIV Reactive/Nonreactive Controls are quality control reagents for use with the Clearview® COMPLETE HIV 1/2 Ass
• 00607158000045 - Chembio DPP HIV 1/2 Rapid Test Control Pack: 2018-07-06 The Chembio HIV Reactive/Nonreactive Controls are quality control reagents for use with the Chembio DPP HIV 1/2 Assay only. Chem
• 00607158000052 - Chembio HIV 1/2 Stat-Pak Assay: 2018-07-06 The Chembio HIV 1/2 STAT-PAK® Assay is a single-use immunochromatographic test for the detection of antibodies to Human Immunod